Actively Recruiting
Non-invasive Cranial Electrical Stimulation for Mealtime Anxiety in Adults With Eating Disorders
Led by Rogers Behavioral Health · Updated on 2025-06-12
30
Participants Needed
1
Research Sites
125 weeks
Total Duration
On this page
Sponsors
R
Rogers Behavioral Health
Lead Sponsor
E
Electromedical Products International, Inc.
Collaborating Sponsor
AI-Summary
What this Trial Is About
The study is to evaluate the feasibility of using a non-invasive brain stimulation device in a sample of inpatients with eating disorders (ED). The study will help researchers evaluate whether their device protocol is practical for eating disorder inpatients as a way to manage eating disorder and anxiety symptoms. A secondary aim of the study is to evaluate preliminary effectiveness of the protocol for reducing pre-meal anxiety during the treatment, and explore effects on eating disorder symptoms over the course of the inpatient admission.
CONDITIONS
Official Title
Non-invasive Cranial Electrical Stimulation for Mealtime Anxiety in Adults With Eating Disorders
Who Can Participate
Eligibility Criteria
You may qualify if you...
-
Age 18-30 years old at the time of enrollment
-
Enrolled in Rogers Behavioral Health Eating Disorder Recovery Program Inpatient Unit at the Oconomowoc, WI clinic location
-
Have a primary diagnosis of any DSM-5 eating disorder (anorexia nervosa, bulimia nervosa, binge eating disorder, avoidant/restrictive food intake disorder, other specified feeding or eating disorder)
-
Ability to communicate effectively using written and spoken English
-
Participant is eligible for mealtime anxiety support based on:
- ≤ 75% meal plan compliance
- Visible anxiety/distress during program meals
- Engagement in compensatory behaviors or self-harm before, during, or after meals, or medical staff judge patient to be at risk of same
You will not qualify if you...
- Metal in the body of any kind (e.g., braces, pacemakers, metal plates or screws, intracranial electrodes, implanted devices/defibrillators, prostheses)
- Currently taking medication that reduces seizure threshold (e.g., clomipramine)
- Cranial pathologies (e.g., holes, plates)
- History of seizure or black-out concussion
- Pregnancy
- Risk of suicide/self-harm by self-strangulation with cranial electrotherapy stimulation (CES) device judged by study medical staff
- Participant calibrates to a stimulation level below 200 microampere (μA)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Rogers Behavioral Health
Oconomowoc, Wisconsin, United States, 53066
Actively Recruiting
Research Team
H
Hana F Zickgraf, Ph.D.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here